Description
Tipol is a new type of therapeutic drug. It is the world's first and currently the only once-weekly glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 receptor agonist approved for type 2 diabetes.
- Semaglutide
- telpotide
- canagliflozin
- retatreotide
- API
- peptide
Production Capacity:
Not informed
Delivery Timeframe:
Immediate
Incoterms:
Not informedPackaging Details:
Not informed
More about
Senova Technology
100-200
Employees
1M - 2M
Sales volume (USD)
100%
% Export sales
Year
Established
Business type
- Industry / Manufacturer
Keywords
- Semaglutide
- tirpatide
- ritatreotide
- canglitide
Contact and location
-
Henry ********
-
+86 1********
-
Shenzhen / | China